|
| N-(2-{(2Z)-2-[1-(1,3-benzodioxol-5-ylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]hydrazinyl}-2-oxoethyl)pyridine-3-carboxamide |
|
Acinetobacter |
Regulation |
Preclinical (in vivo) |
Trebosc V, et al. 2022. Virulence |
|
| 1-phenyl-3-[4-(phenylsulfamoyl)phenyl]thiourea |
|
Escherichia
Salmonella |
Regulation
QseBC |
Preclinical (in vivo)
Preclinical (in vivo) |
Rasko DA, et al. 2008. Science
|
|
| Dephostatin |
|
Salmonella |
PmrAB; SsrAB |
Preclinical (in vivo) |
Tsai CN, et al. 2020. Cell Chem Biol |
|
| 5-Dodecanolide |
|
Streptococcus |
Biofilm; Regulation |
Preclinical (in vivo) |
Valliammai A, et al. 2020. Life Sci |
|
| 2',4'-Dihydroxychalcone |
|
Vibrio |
HlyU |
Preclinical (in vivo) |
Imdad S, et al. 2018. Molecules |
|
| N-(4-oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenylprop-2-ynamide |
|
Vibrio |
HlyU |
Preclinical (in vivo) |
Lee ZW, et al. 2019. Sci Rep |
|
| Fursultiamin |
|
Vibrio |
HlyU |
Preclinical (in vivo) |
Imdad S, et al. 2018. Front Cell Infect Microbiol |
|
| Sanguinarine |
|
Aeromonas |
Biofilm; Regulation |
Preclinical (in vivo) |
Zhang L, et al. 2022. Pathogens |
|
| Maprotiline |
|
Francisella |
Regulation |
Preclinical (in vivo) |
Dean SN, et al. 2015. Virulence |
|
| Ethoxzolamide |
|
Mycobacterium |
Regulation |
Preclinical (in vivo) |
Johnson BK, et al. 2015. Antimicrob Agents Chemother |
|
| | | |
